“Raphael Wisniewski”

As a Name:  Registrant, Group Member and/or Signatory

        

Latest Filing:  2/24/23  as  ↓Group Member

As:  Registrant

        

As:  Group Member  (Co-Filer Non-Registrant:  Partner, Affiliate, etc.)

“Raphael Wisniewski” has been a Group Member with  2  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
2/24/23			Andera Partners	6	SC 13G	PA	Mineralys Therapeutics, Inc.
9/3/13			Biodiscovery 3, FCPR	1	SC 13D	CA	Tobira Therapeutics, Inc.

“Raphael Wisniewski” has/had a Group Member interest in  3  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
2/24/23		PA	Mineralys Therapeutics, Inc.	1	SC 13G		Andera Partners
2/3/21		CA	Axonics, Inc.	5	SC 13D/A		Andera Partners
9/3/13		CA	Tobira Therapeutics, Inc.	1	SC 13D		Biodiscovery 3, FCPR

“Raphael Wisniewski” has been a Group Member with  6  other Group Members:

As Of	Group Member			Filings       #        Latest		With Filer     (Primary)		Issuer     (Primary)
2/24/23		•	Biodiscovery 6 Fpci	1	SC 13G		Andera Partners	PA	Mineralys Therapeutics, Inc.
		•	Laurent Tourtois	1
2/3/21			Biodiscovery 4 FCPR	5	SC 13D/A		Andera Partners	CA	Axonics, Inc.
		•	Biodiscovery 5	5
9/3/13			Edmond De Rothschild Investment Partners	1	SC 13D		Biodiscovery 3, FCPR	CA	Tobira Therapeutics, Inc.
		•	Pierre – Michel Passy	1

As:  Signatory  (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)

“Raphael Wisniewski” has been a Signatory for/with  3  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
2/24/23			Andera Partners	4	SC 13G	PA	Mineralys Therapeutics, Inc.
6/30/21		NY	Citibank, N.A./ADR	1	F-6		Dynacure S.A.
10/30/18		NJ	Wisniewski Raphael	3	3	CA	Axonics, Inc.

“Raphael Wisniewski” has/had a Signatory interest in  5  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
2/24/23		PA	Mineralys Therapeutics, Inc.	1	SC 13G		Andera Partners
10/20/22		MA	LogicBio Therapeutics, Inc.	2	SC 13G/A		Andera Partners
6/30/21			Dynacure S.A.	1	F-6	NY	Citibank, N.A./ADR
2/3/21		CA	Axonics, Inc.	2	SC 13D/A		Andera Partners
1/3/14		CA	Tobira Therapeutics, Inc.	2	4	NJ	Wisniewski Raphael